CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy

Marisol Salgado-Albarrán, Julian Späth, Rodrigo González-Barrios, Jan Baumbach, Ernesto Soto-Reyes

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science